Call

Close
  • Wet age-related macular degeneration (AMD) progresses rapidly. Once you notice symptoms of visual impairment, vision loss may have already occurred
  • Early detection is the best way to catch the progression to wet AMD and preserve vision
  • There are important steps you can take to reduce your risk of developing wet AMD. These can include healthy lifestyle choices and taking AREDS2 vitamins daily
  • It’s also important to monitor your eyes with at-home testing between office visits
  • At-home testing can find tiny changes in your vision much earlier than waiting for your next doctor visit. These changes, if not detected early, could lead to vision loss.

The Amsler grid was developed in the 1940s. By the time you detect vision changes using the Amsler grid, significant vision loss may have already occurred.

  • The Amsler grid is part of an at-home program to monitor AMD. When used alone, changes you see could mean significant vision loss has already occurred
  • ForeseeHome can detect changes related to wet AMD before you notice symptoms or changes on the Amsler grid. This early detection can allow your doctor to start treatment right away. Early detection (before you notice symptoms) and early treatment can result in prevention of vision loss from wet AMD
  • By the time you notice vision distortions on the Amsler grid, it may be too late to protect good, functional vision.

Treatments for wet AMD

  • There are very effective treatments available for wet AMD

  • But once the disease starts, it will continue to advance until your doctor can begin treating you
  • You have the best chance of maintaining good vision and your independence when treatment is started early in the disease process
  • Catching the progression to wet AMD as early as possible before significant vision loss has occurred is critical

Click here to watch Susan’s storyClinical results with ForeseeHome

Privacy Policy Notice of Privacy Practices Patents Disclaimer NotalVision.com Contact Us

FDA Indication for Use

The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration, as an aid in monitoring progression of disease factors causing metamorphopsia including but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.

The ForeseeHome AMD Monitoring Program is only available by physician order and is intended to be used as an addition to regular eye exams.

The ForeseeHome AMD Monitoring Program is covered by Medicare, subject to its coverage requirements for the test, to assess patients with dry AMD who are at risk of developing wet AMD.